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We previously isolated a 41-kDa early antigen of human herpesvirus 6 (HHV-6), which exhibited nuclear localization
and DNA-binding activity (Agulnick et al., 1993). In this study, we observed that a 110-kDa protein was coimmunopre-
cipitated with p41 from HHV-6-infected cells by an anti-p41 antibody. This 110-kDa protein was identified as the HHV-6
DNA polymerase (Pol-6) by an antibody raised against the N terminus of Pol-6. Reciprocal immunoprecipitation and
Western blot analyses confirmed that p41 complexes with Pol-6 in HHV-6-infected cells. In addition, both p41 and Pol-6
were expressed in vitro and shown to form a specific complex. An in vitro DNA synthesis assay using primed M13
single-stranded DNA template demonstrated that p41 not only increased the DNA synthesis activity of Pol-6 but also
allowed Pol-6 to synthesize DNA products corresponding to full-length M13 template (7249 nucleotides). By contrast,
Pol-6 alone could only synthesize DNA of ,100 nucleotides. The functional interaction between Pol-6 and p41 appears
to be specific because they could not be physically or functionally substituted in vitro by their herpes simplex virus 1
homologues. Moreover, as revealed by mutational analysis, both the N and C termini of Pol-6 contribute to its binding
to p41. In the case of p41, the N terminus is required for increasing DNA synthesis but not binding to Pol-6, whereas the
C terminus is totally dispensable. © 1998 Academic Press
INTRODUCTION
Human herpesvirus 6 (HHV-6) is the causative agent of
roseola infantum, a common disease of infancy charac-
terized by a high fever and skin rash (Yamanishi et al.,
1988). In addition, HHV-6 may play a role in some cases
of heterophile-negative mononucleosis, multiple sclero-
sis (Soldan et al., 1997), pneumonitis, and bone marrow
suppression in transplant recipients (reviewed by
Ablashi et al., 1992; Braun et al., 1997). HHV-6 is tropic for
CD41 T cells, which are also the natural targets for HIV
infectivity. Thus, in patients with AIDS, HHV-6 could con-
tribute to the attrition of T cells, which is consistent with
its potential catalytic role in HIV infection (reviewed by
Ablashi et al., 1992; Braun et al., 1997; Lusso et al., 1995)
and its actual detection in many different necropsied
tissues (Corbelliono et al., 1993; Knox and Carrigan,
1994).
HHV-6 has a linear 160-kb DNA genome that has
recently been completely sequenced and analyzed
(Gompels et al., 1995); there are 119 open reading frames
(ORFs) predicted, of which 67% have counterparts in
human cytomegalovirus (HCMV). Although certain struc-
tural and functional genes have been identified (re-
viewed in Braun et al., 1997), little is known about the
nature of many HHV-6 gene products and the manner in
which the virus is regulated.
We previously cloned a 41-kDa early nuclear antigen
of HHV-6, p41, which we suggested could be the viral
processivity factor that functions in DNA replication
(Agulnick et al., 1993). This was based on the fact that
p41 shares 44% amino acid sequence identity with the
HCMV protein ICP36 (Agulnick et al., 1993; Chang and
Balachandran, 1991), which has been shown to function
as a processivity factor (Ertl and Powell, 1992). Both p41
and ICP36 can bind to DNA with the same apparent
affinity (Agulnick et al., 1993; Gibson et al., 1981), and
their coding regions reside at similar locations in their
respective genomes.
Processivity factors associate with certain DNA poly-
merases, allowing them to synthesize extended
stretches of DNA without dissociating from the template.
Two such well-studied proteins, proliferating cell nuclear
antigen (PCNA) of yeast and the subunit of Escherichia
coli DNA polymerase III holoenzyme, have been crystal-
lized (Kong et al., 1992; Krishna et al., 1994). They confer
processivity by forming topological rings encircling du-
plex DNA that tether their polymerases and slide along
the DNA template. Several herpesvirus processivity fac-
tors have been identified, including UL42 of herpes sim-
plex virus 1 (HSV-1) (Gottlieb et al., 1990), BMRF1 of
Epstein–Barr virus (EBV) (Kiehl and Dorsky, 1995; Tsu-
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rumi et al., 1993b), and ICP36 of HCMV (Ertl and Powell,
1992; Mocarski et al., 1995; Weiland et al., 1994). Al-
though the structure and mechanism by which these
viral proteins confer processivity on their polymerases
remain unclear, they have been shown to be critical for
viral replication (Johnson et al., 1991; Ripalti et al., 1995).
Here, we demonstrate that p41 forms a specific com-
plex with HHV-6 DNA polymerase (Pol-6) both in vivo and
in vitro. The DNA synthesis activity of Pol-6 and the
length of DNA products synthesized are greatly in-
creased in the presence of p41. Moreover, both the N and
C termini of Pol-6 contribute to its binding to p41. Al-
though the N terminus of p41 is required for its function,
the C terminus is dispensable.
RESULTS
The p41 protein associates with a 110-kDa protein in
HHV-6-infected cells
We previously suggested that the p41 protein encoded
by HHV-6 is the processivity factor that functions in viral
DNA replication (Agulnick et al., 1993). As shown in the
Western blots (Fig. 1A) probed with an anti-p41 monoclo-
nal antibody, 9A5D12, p41 is present only in HHV-6 (GS or
Z-29)-infected T cells (J-Jhan or Molt-3). To determine
whether any viral or cellular proteins associate with p41,
[35S]methionine-labeled uninfected or HHV-6-infected T
cell extracts were immunoprecipitated with the anti-p41
antibody and analyzed by SDS–PAGE. As shown in Fig.
1B, a 110-kDa protein was coimmunoprecipitated with
p41 from both GS- and Z-29-infected T cell extracts
(lanes 4 and 6) but not from uninfected T cell extracts
(lanes 3 and 5). It is noted that p41 proteins synthesized
in vivo (lanes 4 and 6) and in vitro (lanes 1 and 2)
comigrated. It was reasonable to suggest that the 110-
kDa protein could be the viral DNA polymerase because
it associated with p41 and its apparent molecular weight
corresponded to what was predicted from the ORF of
HHV-6 DNA polymerase (Gompels et al., 1995; Teo et al.,
1991).
The 110-kDa protein is HHV-6 DNA polymerase
To determine whether the 110-kDa protein from in-
fected cells is the authentic HHV-6 DNA polymerase
(Pol-6), we prepared an antiserum, Pol6N159, directed
against the N-terminal 159 amino acids of Pol-6, which
had been overexpressed in E. coli. As shown in the
Western blot of Fig. 2A, the anti-Pol-6 antibody recog-
nized the 110-kDa protein that was coimmunoprecipi-
tated with p41 by the anti-p41 antibody from HHV-6 (Z-29
strain)-infected (lane 6) but not uninfected (lane 5) cell
extracts. The 110-kDa protein migrated to the same po-
sition as full-length Pol-6 that was overexpressed from
Spodoptera frugiperda (Sf9) cells (baculo-Pol-6, lane 4).
Reciprocally, as shown in Fig. 2B, a Western blot using
the anti-p41 antibody revealed that p41 was coimmuno-
precipitated with Pol-6 by the anti-Pol-6 antibody from
HHV-6-infected (lane 6) but not uninfected (lane 5) cell
extracts. The p41 product that was coimmunoprecipi-
tated by the anti-Pol-6 antibody migrated to the same
position as p41 that was detected directly by the anti-p41
antibody from HHV-6-infected cell extracts (compare
FIG. 1. A 110-kDa protein is coimmunoprecipitated with p41 from HHV-6-infected cells. (A) Western blot analysis. Cell extracts of 106 uninfected or
HHV-6 (GS or Z-29 strain)-infected T cells (J-Jhan or Molt-3) were fractionated on SDS 4–20% polyacrylamide gels, transferred to Millipore Immobilon-P
membranes, and probed with anti-p41 monoclonal antibody 9A5D12. (B) Immunoprecipitation; 107 uninfected or HHV-6-infected T cells were labeled
with [35S]methionine and immunoprecipitated by anti-p41 antibody (lanes 3–6). The immunoprecipitates were fractionated on SDS 4–20% polyacryl-
amide gel and examined by autoradiography. In vitro translated (IVT) p41 was loaded directly (1 ml, input, lane 1) or after immunoprecipitation (5 ml,
lane 2) by the anti-p41 antibody.
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lanes 6 and 2). No products were observed with preim-
mune antisera (Fig. 2A, lanes 1–3, and Fig. 2B, lanes 3
and 4). Thus, the 110-kDa protein that associates with
p41 in HHV-6-infected cells is the viral DNA polymerase
(Pol-6).
The p41 protein specifically associates with HHV-6
DNA polymerase in vitro
To facilitate the study of HHV-6 DNA polymerase
(Pol-6) and p41, both proteins were expressed in vitro
using a coupled transcription–translation system. To ex-
amine the specificity of protein–protein interaction, the
well-characterized HSV-1 DNA polymerase UL30 and its
processivity factor UL42 were also expressed in vitro.
The [35S]methionine-labeled in vitro translated proteins
(p41, Pol-6, UL42, and UL30) are represented in Figs. 3A,
lanes 1–3, and 3B, lanes 1–3. A binding assay was
performed to determine whether Pol-6 and p41 can form
a specific complex in vitro. When various combinations
of these proteins were examined, p41 and UL42 were
FIG. 2. The 110-kDa protein coprecipitated with p41 is the HHV-6 DNA polymerase (Pol-6). (A) Cell extracts of 107 uninfected or HHV-6 (Z-29)-infected
Molt-3 cells were first immunoprecipitated with anti-p41 antibody and then analyzed by Western blot using either preimmune antiserum (lanes 2 and
3) or anti-Pol-6 antibody (lanes 5 and 6). Pol-6 expressed from Sf9 cells (baculo-Pol-6) was recognized directly in Western blot analysis by anti-Pol-6
antibody (lane 4) but not by preimmune antiserum (lane 1). (B) Cell extracts of 107 uninfected or HHV-6 (Z-29)-infected Molt-3 cells were first
immunoprecipitated with either preimmune antiserum (lanes 3 and 4) or anti-Pol-6 antibody (lanes 5 and 6) and then analyzed by Western blot analysis
using anti-p41 antibody. Cell extracts of 106 uninfected or HHV-6 (Z-29)-infected Molt-3 cells were analyzed directly by Western blot analysis using
anti-p41 antibody (lanes 1 and 2).
FIG. 3. p41 and Pol-6 form a specific complex in vitro. Pol-6, p41, UL30 (HSV-1 DNA polymerase), and UL42 (HSV-1 processivity factor) were
translated in vitro and labeled with [35S]methionine. Individual or combined proteins were immunoprecipitated by either anti-p41 antibody 9A5D12 (A,
lanes 4–7) or anti-Pol-6 antibody Pol6N159 (B, lanes 4–7). In (B), to obtain better resolution of p41 in lane 6, [35S]methionine-labeled p41 was
coimmunoprecipitated with unlabeled (*) Pol-6 (lane 8). The immunoprecipitates were fractionated on SDS 4–20% polyacrylamide gels and examined
by autoradiography. For both (A) and (B), 20% input of translated proteins used in immunoprecipitation is represented.
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shown to complex only with their cognate polymerases.
As shown in Fig. 3A, Pol-6 (lane 6), but not UL30 (lane 7),
was coimmunoprecipitated with p41 by the anti-p41
monoclonal antibody. Clearly, Pol-6 was immunoprecipi-
tated indirectly (lane 6) because the anti-p41 antibody
could not directly recognize Pol-6 alone (lane 5). Recip-
rocally, the results of Fig. 3B demonstrated that p41
(lanes 6 and 8), but not UL42 (lane 7), interacted with
Pol-6. The formation of specific complexes observed with
these in vitro translated proteins further indicates that
the association between Pol-6 and p41 can occur in the
absence of any other viral gene products.
The p41 protein greatly increases DNA synthesis
activity of HHV-6 DNA polymerase
To determine whether the interaction between p41 and
Pol-6 is functionally significant in DNA replication, an in
vitro DNA synthesis assay was performed that used M13
single-stranded DNA (ssDNA) with an annealed oligonu-
cleotide primer as the template. The incorporation of
[a-32P]dCTP into newly synthesized DNA products was
measured to indicate the DNA synthesis activity of Pol-6
in the absence or presence of p41. As shown in Fig. 4,
compared with the background level by mock-translated
protein, there was only a slight nucleotide (nt) incorpo-
ration by Pol-6 alone. The p41 protein did not exhibit any
catalytic activity. However, when p41 was combined with
Pol-6, the level of incorporation was dramatically in-
creased, 15-fold above that of Pol-6 alone. Similarly, as
shown previously (Gottlieb et al., 1990), the HSV-1 pro-
cessivity factor UL42 greatly increased the DNA synthe-
sis activity of the HSV-1 DNA polymerase UL30. More-
over, consistent with the inability of the HHV-6 and HSV-1
proteins to form complexes with one another, UL42 failed
to stimulate the activity of Pol-6, and p41 failed to stim-
ulate the activity of UL30.
The p41 protein enables Pol-6 to synthesize fully
extended DNA products
If p41 is the processivity factor of HHV-6, it should
enable Pol-6 to synthesize extended DNA products. To
evaluate the relative length of DNA synthesized by Pol-6
in the absence or presence of p41, labeled DNA mole-
cules produced in the DNA synthesis assay described
above were fractionated on a 1.3% alkaline agarose gel.
As revealed in Fig. 5, the addition of p41 to Pol-6 resulted
in a dramatic increase in the length of synthesized DNA
molecules. Pol-6 alone could synthesize only DNA prod-
ucts that were ,100 nt in length (Figs. 5A, lane 2, and
5B), whereas the addition of p41 enabled synthesis of
DNA corresponding to the 7249-nt full-length M13
ssDNA (Figs. 5A, lane 4, and 5B). The addition of p41 to
Pol-6 also contributed to the appearance of a large abun-
dance of short DNA molecules that are up to 400 nt in
length and a less abundant, intermediate-size range of
DNA molecules (400–7000 nt in length). The synthesis of
significantly longer DNA molecules by the addition of p41
to Pol-6 was similar to what was observed when the
well-characterized HSV-1 processivity factor UL42 was
combined with its DNA polymerase UL30 (Fig. 5A, lanes
6–8). Importantly, UL42 did not increase the DNA synthe-
sis of Pol-6 (Fig. 5A, lane 5), nor did p41 increase the
DNA synthesis of UL30 (lane 9), which is consistent with
the inability of the HHV-6 and HSV-1 proteins to interact.
Taken together, these results suggest that p41 is the
processivity factor of HHV-6 and further argue that the
functional interactions between herpesvirus processivity
factors and their DNA polymerases are specific.
Functional analyses of Pol-6 and p41 deletion
mutants
To determine functionally important regions of p41,
several deletion mutants of p41 were generated from the
wild-type (wt) p41 ORF (368 residues) (Fig. 6A) and ex-
pressed in vitro using the coupled transcription–transla-
tion system (Fig. 6B). These mutant proteins were exam-
ined for their abilities to bind Pol-6 in the in vitro binding
assay (Fig. 6C) and were tested for their abilities to
increase DNA synthesis in vitro by measuring dNTP
incorporation (Fig. 6D) and the length of DNA products
synthesized (Fig. 6E). The DN130 mutant, which has 130R
deleted from the N terminus of p41, failed to bind Pol-6 or
increase its DNA synthesis activity. By contrast, DC31,
which has a small deletion of 31R from the C terminus of
p41, retained the ability to bind Pol-6 and to increase
FIG. 4. The DNA synthesis activity of Pol-6 is greatly increased in the
presence of p41. The DNA synthesis activity of individual or combined
in vitro translated proteins was determined by the in vitro DNA synthe-
sis assay using primed M13 ssDNA template. The activity is indicated
by the incorporation of [a-32P]dCTP into synthesized DNA products.
UL30 and UL42 are the DNA polymerase and the processivity factor of
HSV-1, respectively. Approximately equivalent amounts of Pol-6 or UL30
and of p41 or UL42, respectively, were used in the assay. (Mock)
Translation of the pTM1 plasmid vector without a coding insert.
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DNA synthesis. Interestingly, DN30DC31, which has an
additional small deletion of 30R from the N terminus of
DC31, could still bind Pol-6 but failed to increase DNA
synthesis. It is possible that this loss of function could be
due to inability of DN30DC31 to bind DNA, which has yet
to be determined. It is noted that the weak binding of wt
and mutant p41 proteins to Pol-6 seen in Fig. 6B (and Fig.
3B) may arise from the interference by the antibody
raised against the N terminus of Pol-6, which is a region
of the polymerase required for binding to p41 as dem-
onstrated below. These results suggest that the extreme
C terminus of p41 is totally dispensable for function,
whereas the extreme N terminus of p41 is required for
increasing DNA synthesis but not for binding to Pol-6.
Similarly, several deletion mutants were generated
from the wt Pol-6 ORF (1016 residues) (Fig. 7A). These
Pol-6 mutant proteins were expressed in vitro and exam-
ined for their abilities to bind p41 (Fig. 7B), and they were
tested for their abilities to synthesize DNA by measuring
dNTP incorporation (Fig. 7C) and the lengths of DNA
products (Fig. 7D). As revealed by the in vitro binding
assay, both the N-terminal (DN77) and C-terminal
(DC235) deletion mutants of Pol-6 failed to bind to p41,
whereas a internal deletion mutant (D145–777) was able
to retain some binding activity. These results suggest
that both the N-terminal 77R and C-terminal 235R of Pol-6
are important for its binding to p41. However, none of
these Pol-6 mutants retained polymerase activity in the in
vitro DNA synthesis assay.
DISCUSSION
In this study, we show that p41 forms a complex with
Pol-6 in HHV-6 infected T cells. We further demonstrate
that the interaction is functional in that p41 greatly in-
creases DNA synthesis activity of Pol-6 in vitro. Recent
sequencing of the complete HHV-6 genome (Gompels et
al., 1995) predicts that it encodes at least seven con-
served gene products, which in HSV-1 (Wu et al., 1988)
have been shown to be required for viral DNA replica-
tion. In addition to Pol-6 and p41 as described here, an
origin binding protein that recognizes an HHV-6 lytic
origin of replication has been identified (Dewhurst et al.,
1993; Inoue et al., 1994; Lawrence et al., 1995). A putative
helicase–primase complex (U43, U74, and U77) and an
ssDNA-binding protein (U41) were revealed from the
HHV-6 genome sequence (Gompels et al., 1995; Nicho-
las, 1994). Although U43, U74, U77, and U41 are likely to
be required for viral replication in vivo, they are dispens-
able in the in vitro DNA synthesis assay presented here,
FIG. 5. p41 allows Pol-6 to synthesize fully extended DNA products. (A) The DNA synthesis assay using primed M13 ssDNA template was performed
with individual or combined in vitro translated Pol-6, p41, UL30 (HSV-1 DNA polymerase), and UL42 (HSV-1 processivity factor) as indicated. (Mock)
Translation of the pTM1 plasmid vector without a coding insert. The synthesized [a-32P]dCTP-labeled DNA products (lanes 1–9) were fractionated on
a 1.3% alkaline agarose gel and examined by autoradiography. The positions of full-length M13 and short DNA products (,100 nt) are indicated by
M13 marker (lane 10) and l marker (not shown). (B) A PhosphorImager scan of the first four lanes of the gel (A) shows the quantitative size distribution
of the synthesized DNA products.
214 LIN AND RICCIARDI
which takes advantage of the use of a primed M13
ssDNA as the template. In this in vitro assay, the addition
of p41 allowed Pol-6 to synthesize fully extended M13
DNA products (7249 nt). However, there still was an
abundance of smaller DNA products synthesized when
both p41 and Pol-6 were present. These smaller DNA
products may be generated from obstructed DNA syn-
thesis due to the secondary structure of M13 ssDNA. The
addition of ssDNA-binding protein in the assay may fur-
ther assist the DNA synthesis by stabilizing ssDNA struc-
ture, as has been demonstrated in other viral systems
(Hernandez and Lehman, 1990; McDonald et al., 1997).
Key features of processivity factors are their abilities to
tether polymerases and to slide along the DNA template.
The structures of two processivity factors, PCNA of yeast
and the b subunit of E. coli DNA polymerase III holoen-
zyme, have been determined (Kong et al., 1992; Krishna
et al., 1994). Although these two proteins do not share
significant sequence homology, PCNA trimer and b sub-
unit dimer form virtually identical topological ring struc-
tures encircling duplex DNA. These ring structures act as
“sliding clamps” that tether their polymerases and travel
along the DNA template. PCNA and b subunit also re-
quire “clamp loader” RF-C or g complex, respectively, to
be enzymatically loaded onto the DNA template. In con-
trast, p41 and other herpesvirus processivity factors
(UL42 of HSV-1, BMRF1 of EBV, ICP36 of HCMV) all have
intrinsic abilities to bind DNA and thus do not require
other proteins to be loaded onto the DNA template
(Agulnick et al., 1993; Gallo et al., 1988; Gibson et al.,
1981; Kiehl and Dorsky, 1995; Tsurumi, 1993a). Interest-
ingly, the high DNA-binding affinities of these proteins do
not seem to prevent their movement along the DNA
template. The structure and mechanism of these viral
processivity factors remain to be determined.
In this study, we also show that p41 of HHV-6 and UL42
FIG. 6. Functional analysis of p41 deletion mutants. (A) Schematic representation of wt (368 amino acid residues) and deletion mutants of p41 and
summary of the results. (B) Expression of p41 mutants. In vitro translated [35S]methionine-labeled wt and mutant p41 were fractionated on SDS 4–20%
polyacrylamide gel and examined by autoradiography. (C) Binding of p41 mutants to wt Pol-6. [35S]Methionine-labeled p41 wt or mutant proteins in
the absence or presence of unlabeled Pol-6 were immunoprecipitated by anti-Pol-6 antibody. Immunoprecipitates were fractionated on SDS 4–20%
polyacrylamide gel and examined by autoradiography. (D) Affect of p41 mutants on DNA synthesis activity of wt Pol-6. Activity is determined by
incorporation of [a-32P]dCTP in the DNA synthesis assay using primed M13 ssDNA template. (E) The lengths of DNA products synthesized in (D) were
analyzed on a 1.3% alkaline agarose gel. The positions of full-length M13 and short DNA products (,100 nucleotides) are determined from M13 marker
(lane 9) and l marker (lane 10).
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of HSV-1, which share 20% amino acid sequence identity
(Agulnick et al., 1993), cannot physically or functionally
substitute for one another. Thus, even if these herpesvi-
rus processivity factors form similar structures (as in the
case of yeast PCNA and E. coli b subunit), they appear to
function with their own polymerases. Our results imply
that the specificity of each processivity factor resides in
forming a complex only with its own DNA polymerase.
However, it remains to be determined whether heterolo-
gous interactions of DNA polymerases and processivity
factors are possible between HHV-6 and more closely
related herpesviruses, such as HCMV and HHV-7.
Herpesvirus processivity factors have been shown to
be critical for viral replication (Johnson et al., 1991; Ripalti
et al., 1995). Significantly, the UL42 null HSV-1 mutant
failed to infect and replicate in Vero cells (Johnson et al.,
1991). Also, an antisense mRNA targeted against ICP36
strongly inhibited HCMV replication (Ripalti et al., 1995).
The results of this study show that an interaction be-
tween Pol-6 and p41 does occur in HHV-6-infected cells
and is critical for DNA replication in vitro. The develop-
ment of a plaque assay (currently unavailable) for char-
acterizing HHV-6 mutants would help to further demon-
strate the importance of p41 in vivo.
Because the herpesvirus processivity factors are es-
sential for viral DNA replication and appear to be specific
for their own DNA polymerases, they are potentially
excellent antiviral targets. Indeed, a synthetic peptide
corresponding to the HSV-1 UL30–UL42 interface effec-
tively blocked processive DNA synthesis by HSV-1 poly-
merase in vitro (Digard et al., 1995). Therefore, defining
the interaction domains of Pol-6 and p41 not only may
help to understand the mechanism of these proteins but
also could lead to the design of antiviral agents that
specifically inhibit HHV-6 replication. In the case of p41,
the extreme N-terminal 30 amino acid residues appear to
be required for its ability to increase DNA synthesis but
not for its ability to bind Pol-6, whereas the extreme
C-terminal 31 residues appear to be totally dispensable
for function. This is consistent with the processivity fac-
tors of three other herpesviruses (UL42 of HSV-1, BMRF1
of EBV, ICP36 of HCMV), in which about one fourth of the
FIG. 7. Functional analysis of Pol-6 deletion mutants. (A) Schematic representation of wt (1016 amino acid residues) and deletion mutants of Pol-6
and a summary of the results. (B) Binding of Pol-6 mutants to wt p41. In vitro translated [35S]methionine-labeled Pol-6 wt or mutant proteins in the
absence or presence of unlabeled p41 were immunoprecipitated by anti-p41 antibody. The immunoprecipitates were fractionated on SDS 4–20%
polyacrylamide gel and examined by autoradiography. Input represents 20% of translated proteins used in immunoprecipitation. (C) DNA synthesis
activity of Pol-6 mutants in the absence or presence of wt p41. Activity is determined by incorporation of [a-32P]dCTP in the DNA synthesis assay using
primed M13 ssDNA template. (D) The lengths of DNA products synthesized in (C) were analyzed on a 1.3% alkaline agarose gel. The positions of
full-length M13 and short DNA products (,100 nt) are determined from the M13 marker (lane 1) and l marker (lane 2).
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C terminus can be deleted without loss of function (Di-
gard et al., 1993b; Kiehl et al., 1995; Monahan et al., 1993;
Tenney et al., 1993a; Weiland et al., 1994). In the case of
Pol-6, our results suggest that both the N and C termini
contribute to its binding to p41. By contrast, the C-termi-
nal 228 amino acids of HSV-1 Pol (UL30) are sufficient to
bind UL42; the extreme C-terminal 35 residues are cru-
cial for the binding (Digard et al., 1993a; Tenney et al.,
1993b). Fine mutational and structural analyses of p41
and Pol-6 will provide the details of their interaction and
function.
MATERIALS AND METHODS
Cell lines and viruses
Two T cell lines, J-Jhan and Molt-3, were propagated at
37°C in RPMI 1640 medium (GIBCO) containing 10% fetal
bovine serum (FBS; Hyclone). J-Jhan and Molt-3 were
infected by HHV-6 strains GS (variant A) and Z-29 (variant
B), respectively. Continuous infected cultures were main-
tained by adding infected T cells, exhibiting 80% cyto-
pathic effect, to uninfected T cells at a ratio of 1:5. Sf9
cells were grown as described previously (Willis et al.,
1997).
Plasmid constructs
The HHV-6 DNA polymerase (Pol-6) gene was ampli-
fied from an HHV-6 (variant A) genomic DNA clone,
pRPM4.4 (Teo et al., 1991), by PCR using two oligonucle-
otides [N-Pol (59-CGCGCGCCATGGATTCGGTGTCG-39)
and C-Pol (59-GCGCGAATTCCATTCACATTACCTCTGC-
39)] to create an NcoI site flanking the 59 end and an
EcoRI site flanking the 39 end of the Pol-6 coding region,
respectively. To construct pTM1-Pol-6, the amplified
Pol-6 gene was cloned into the NcoI and EcoRI sites of
the in vitro transcription–translation vector pTM1. To con-
struct pAcHLT-Pol-6, the Pol-6 gene was cloned from
pTM1-Pol-6 into the NcoI and SacI sites of the baculovi-
rus transfer vector pAcHLT-B (InVitrogen). The plasmid
pET-PolN, encoding the N-terminal 159 amino acids of
Pol-6, was generated by subcloning the coding region
between the NcoI and PstI sites of pTM1-Pol-6 into
pET-21b vector (Novagen). To construct pTM1-p41, a
pBluescript plasmid containing the HHV-6 (variant A) p41
gene (Agulnick et al., 1993) was amplified by PCR using
two oligonucleotides [N-p41 (59-CTATCCATGGAGCGCG-
GTAGTC-39) and C-p41 (59-CAGAATTCAGACGACGCAT-
CTC-39)] to create an NcoI site flanking the 59 end and a
EcoRI site flanking the 39 end of the p41 coding region,
respectively. The amplified p41 gene was cloned into the
NcoI and EcoRI sites of pTM1. All of the Pol-6 deletion
mutants (DN77, DC235, D145–777) were generated by
cleaving wt Pol-6 ORF with corresponding restriction
enzymes, followed by subsequent cloning into pTM1
vector. All of the p41 deletion mutants (DN130, DC31,
DN30DC31) were generated by PCR amplification using
oligonucleotides tagged with the 59 NcoI site or 39 EcoRI
site, followed by subsequent cloning into pTM1 vector.
All of the plasmid constructs were confirmed by DNA
sequencing and restriction enzyme digestion and were
introduced into E. coli DH5a (GIBCO).
Antibodies
The N-terminal 159-amino-acid-coding region of Pol-6,
cloned into the expression vector pET-PolN that supplies
an C-terminal 6xHis tag, was overexpressed in E. coli by
induction with 1 mM isopropyl-b-D-thiogalactopyrano-
side. The 6xHis-PolN protein was purified by Clontech
TALONTM metal affinity resin under denaturing condi-
tions, dialyzed, and used to generate a rabbit polyclonal
antiserum, Pol6N159 (Cocalico). The antiserum was pu-
rified by an antigen affinity column, which was generated
by coupling 6xHis-PolN protein to a QIAGEN Ni21-NTA
agarose column (Gu et al., 1994). The mouse monoclonal
antibody 9A5D12 (tissue culture supernatant), which rec-
ognizes the HHV-6 p41 protein, was generously provided
by Dr. Bala Chandran.
Expression of Pol-6 in Sf9 cells
A recombinant baculovirus was generated by cotrans-
fection of pAcHLT-Pol-6, which supplied a 6xHis tag to
the N terminus of the Pol-6 gene and BaculoGold linear
DNA (Pharmingen) into Sf9 cells. The 6xHis recombinant
Pol-6 protein (baculo-Pol-6) was overexpressed in Sf9
cells (Willis et al., 1997) and purified by an Ni21-NTA
Agarose column (QIAGEN).
Western blot analysis
Cell extracts or proteins were fractionated on SDS
4–20% polyacrylamide gels (BioRad) and electrophoreti-
cally transferred to Millipore Immobilon-P transfer mem-
branes. To detect p41, the blot was incubated with
9A5D12 (1:10 dilution) for 2 h and then with goat anti-
mouse IgG horseradish peroxidase (Boehringer-Mann-
heim) for 1 h. To detect Pol-6, the blot was incubated with
affinity-purified Pol6N159 (1:500 dilution) and then with
goat anti-rabbit IgG-HRP. The blots were visualized
through enhanced chemiluminescence (Amersham).
Radiolabeling of cells
Uninfected or HHV-6-infected T cells (107) were
washed with RPMI (-Met, GIBCO) twice and then labeled
in RPMI (-Met) containing 250 mCi of L-[35S]methio-
nine (.1000 Ci/mmol; Amersham) and 10% dialyzed FBS
for 24 h.
Immunoprecipitation
Uninfected or HHV-6-infected T cells (107) were lysed
in 1 ml of buffer A (50 mM Tris–HCl, 150 mM NaCl, and
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1% Nonidet P-40) on ice for 30 min. The cell lysates were
incubated with either 50 ml of anti-p41 antibody (9A5D12)
or 1 mg of purified anti-Pol-6 antibody (Pol6N159) for 2 h
and then with 20 ml of Protein A–Sepharose (Pharmacia)
for 1 h at 4°C. After washing extensively with buffer A,
the immunoprecipitates were eluted by boiling in Lae-
mmli’s buffer and fractionated on SDS 4–20% polyacryl-
amide gel.
In vitro transcription–translation
Both unlabeled and [35S]methionine-labeled proteins
were synthesized in vitro using the Promega TNT-cou-
pled reticulocyte lysate systems. All the Pol-6 and p41
constructs cloned in pTM1 vector were transcribed–
translated by using T7 RNA polymerase TNT system.
HSV-1 UL30 and UL42 were transcribed–translated from
p911 and pINGUL42DMCS (generous gifts from Dr.
Donald Coen), respectively, using T3 or SP6 RNA poly-
merase TNT system.
In vitro binding assay
Individual or combined in vitro translated proteins
were incubated with either 40 ml of anti-p41 antibody
(9A5D12) or 1 mg of purified anti-Pol-6 antibody
(Pol6N159) at 4°C for 2 h in the presence of 100 mM KCl,
5 mM MgCl2, 50 mM Tris–HCl (pH 7.6), and 0.1% Nonidet
P-40 and then with 20 ml of Protein A–Sepharose at 4°C
for 1 h. After washing extensively with a buffer containing
100 mM KCl, 5 mM MgCl2, 50 mM Tris–HCl (pH 7.6), and
1% Nonidet P-40, the immunoprecipitates were eluted by
boiling in Laemmli’s buffer and fractionated on SDS
4–20% polyacrylamide gel.
In vitro DNA synthesis assay
In vitro DNA synthesis assays were performed essen-
tially as described by Digard et al. (1993b). M13 primed
template was prepared by annealing M13 Universal se-
quencing primer to M13mp18(1) ssDNA (Pharmacia) in
the presence of 100 mM NaCl, 1 mM EDTA, and 50 mM
Tris–HCl (pH 7.6). The annealing reaction was performed
by heating the template and primer at 90°C for 5 min
followed by slow cooling to room temperature. Excess
primer was removed by filtration through a Centricon-100
spin filter (Amicon). For each 50 ml of reaction, 5 ml of
each in vitro translated protein was added to a buffer
containing 100 mM (NH4)2SO4; 20 mM Tris–HCl (pH 7.5);
3 mM MgCl2; 0.1 mM EDTA; 0.5 mM dithiothreitol; 4%
glycerol; 40 mg/ml bovine serum albumin; 60 mM each of
dATP, dGTP, and dTTP; 10mM [a-32P]dCTP (3000 Ci/
mmol; New England Nuclear); and 50 fmol of M13 primed
template and incubated at 37°C for 30 min.
To measure the incorporation of [a-32P]dCTP, 5 ml of
each reaction was precipitated on ice for 10 min with 50
ml of 5% trichloroacetic acid (TCA)–20 mM sodium pyro-
phosphate and then captured on a Whatman RF/A glass-
fiber filter. The filter was washed extensively with 5%
TCA–20 mM sodium pyrophosphate, rinsed with 70%
ethanol, dried, and counted in a Beckman liquid scintil-
lator model LS2800.
To determine the length of labeled DNA products that
were synthesized, the remainder of the reaction was
incubated at 37°C for 1 h with 50 ml of 1% SDS, 10 mM
EDTA, 10 mM Tris–HCl (pH 8), and 200 mg/ml proteinase
K, followed by phenol–chloroform extraction. The synthe-
sized DNA products were ethanol precipitated in the
presence of 1 M ammonium acetate, resuspended in 50
ml of gel-loading buffer (50 mM NaOH, 2.5 mM EDTA,
25% glycerol, and 0.025% bromocresol green), and then
fractionated on a 1.3% alkaline agarose gel. The gel was
dried and subjected to autoradiography or analysis with
a PhosphorImager (Molecular Dynamics).
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